Avient (AVNT) vs Cabot (CBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Avient (AVNT) has outperformed Cabot (CBT) over the past year, gaining 46.3% versus a gain of 14.2%. Over five years, CBT leads with a +26.2% price change compared with -25.4% for AVNT. Avient is the larger company by market cap ($3.93 billion vs $3.62 billion), about 1.1 times the size, while Cabot is growing revenue faster (+0.8% vs +0.6%).
On valuation, Cabot trades at a lower forward P/E (9.5x vs 11.7x for Avient). Avient pays a dividend yielding 2.57%, while Cabot does not currently pay one. Cabot converts more of its revenue into profit, with a net margin of 5.7% versus 2.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVNT | CBT |
|---|---|---|
| Share price | $42.84 | $70.48 |
| Market cap | $3.93B | $3.62B |
| 1-day change | -1.13% | -3.23% |
| YTD return | +37.13% | +6.34% |
| 1-year return | +46.26% | +14.21% |
| 5-year return | -25.37% | +26.24% |
| P/E ratio (TTM) | 21.97 | 17.53 |
| Forward P/E | 11.75 | 9.50 |
| EPS (TTM) | $1.95 | $4.02 |
| Dividend yield | 2.57% | 2.68% |
| Annual dividend | $1.10 | $0.00 |
| Revenue (latest FY) | $3.26B | $3.74B |
| Revenue growth (YoY) | +0.61% | +0.83% |
| Net income (latest FY) | $81.90M | $213.00M |
| Gross margin | 31.15% | 21.61% |
| Operating margin | 6.24% | 12.74% |
| Net margin | 2.51% | 5.69% |
| 52-week high | $49.08 | $94.53 |
| 52-week low | $28.50 | $60.68 |
| Distance from 52-week high | -12.71% | -25.44% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +24.02% | +21.07% |
| Average volume | 775.03K | 392.73K |
| Shares outstanding | 91.75M | 51.34M |
| Employees | 9,000 | 4,064 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVNT has outperformed CBT by 32.0 percentage points over the past year.
- Avient trades at a higher earnings multiple (22.0x vs 17.5x trailing P/E).
About Avient
AVNT stock →Avient Corporation operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. The company operates in two segments, Color, Additives and Inks; and Specialty Engineered Materials.
Industrials · Major Chemicals · 9,000 employees
About Cabot
CBT stock →Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals.
Industrials · Major Chemicals · 4,064 employees
AVNT vs CBT FAQ
Which is bigger, Avient or Cabot?
Avient (AVNT) is larger, with a market capitalization of $3.93B compared with $3.62B for Cabot (CBT).
Which stock has performed better over the past year, AVNT or CBT?
AVNT returned +46.26% over the past 12 months, compared with +14.21% for CBT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, AVNT or CBT?
CBT has the lower trailing P/E at 17.5, versus 22.0 for AVNT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Avient or Cabot?
Cabot has the higher yield at 2.68%, compared with 2.57% for Avient.
Are Avient and Cabot in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.